Sarcomatoid mesothelioma (SM) is diagnosed less often than epithelioid disease, and can be challenging to diagnose as BAP1 loss is seen less frequently than in epithelioid disease. This evidence concerns the gene BAP1 and sarcomatoid mesothelioma.